Business News November 29, 2024 Elon Musk’s DOGE partner Vivek Ramaswamy says they’ll scrutinize $6.6 billion Biden loan to Tesla rival Rivian November 29, 2024 Elon Musk’s DOGE partner Vivek Ramaswamy says they’ll scrutinize $6.6 billion Biden loan to Tesla rival Rivian November 29, 2024 Elon Musk’s DOGE partner Vivek Ramaswamy says they’ll scrutinize $6.6 billion Biden loan to Tesla rival Rivian November 29, 2024 Notre Dame rises from the ashes: Macron unveils cathedral’s triumphant comeback from 2019 inferno November 29, 2024 How Office Depot’s president builds trust with shoppers in a digital world November 29, 2024 Planning a charity gift? Try these 401(k)-style accounts to max giving—and lower your tax bill November 29, 2024 ‘Dr Doom’ Nouriel Roubini believes a second Trump term could push inflation as high as 5% November 29, 2024 People will do anything to get away from ultra-processed foods—from ‘no recipe recipes’ to making anything edible from scratch November 29, 2024 The companies betting on male birth control step closer to approval—and into an uncertain political chapter « Previous 1 2 3 4 … 37 38 39 40 41 42 43 44 45 … 97 98 99 100 Next »
November 29, 2024 Elon Musk’s DOGE partner Vivek Ramaswamy says they’ll scrutinize $6.6 billion Biden loan to Tesla rival Rivian
November 29, 2024 Elon Musk’s DOGE partner Vivek Ramaswamy says they’ll scrutinize $6.6 billion Biden loan to Tesla rival Rivian
November 29, 2024 Elon Musk’s DOGE partner Vivek Ramaswamy says they’ll scrutinize $6.6 billion Biden loan to Tesla rival Rivian
November 29, 2024 Notre Dame rises from the ashes: Macron unveils cathedral’s triumphant comeback from 2019 inferno
November 29, 2024 Planning a charity gift? Try these 401(k)-style accounts to max giving—and lower your tax bill
November 29, 2024 ‘Dr Doom’ Nouriel Roubini believes a second Trump term could push inflation as high as 5%
November 29, 2024 People will do anything to get away from ultra-processed foods—from ‘no recipe recipes’ to making anything edible from scratch
November 29, 2024 The companies betting on male birth control step closer to approval—and into an uncertain political chapter